Galderma

Industry / private company


Location: Lausanne, Switzerland (CH) CH

ROR: https://ror.org/05fswdm20

close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Efficacy and Safety of Nemolizumab in Patients With Moderate to Severe Prurigo Nodularis: The OLYMPIA 1 Randomized Clinical Phase 3 Trial. (2025) Ständer S, Yosipovitch G, Legat FJ, Reich A, Paul C, Simon D, Naldi L, et al. Journal article